• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    5 Analysts Have This to Say About Greenhill & Co

    5/23/23 10:02:37 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance
    Get the next $GHL alert in real time by email

    Analysts have provided the following ratings for Greenhill & Co (NYSE:GHL) within the last quarter:

    Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
    Total Ratings 0 1 1 1 2
    Last 30D 0 0 1 0 0
    1M Ago 0 1 0 1 0
    2M Ago 0 0 0 0 2
    3M Ago 0 0 0 0 0

    In the last 3 months, 5 analysts have offered 12-month price targets for Greenhill & Co. The company has an average price target of $11.9 with a high of $20.00 and a low of $6.50.

    Below is a summary of how these 5 analysts rated Greenhill & Co over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

    price target chart

    This current average has increased by 38.05% from the previous average price target of $8.62.

    Stay up to date on Greenhill & Co analyst ratings.

    If you are interested in following small-cap stock news and performance you can start by tracking it here.

    How Are Analyst Ratings Determined?

    Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

    Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

    Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $GHL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GHL

    DatePrice TargetRatingAnalyst
    4/28/2022$16.50 → $12.00Mkt Perform → Underperform
    Keefe Bruyette
    3/9/2022$18.50 → $17.00Neutral
    Piper Sandler
    7/14/2021$15.50Underperform → Market Perform
    Keefe, Bruyette & Woods
    More analyst ratings

    $GHL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors

    Believes That Incremental Changes Since Last Annual Meeting Are Insufficient to Address the Poor Corporate Governance and Concerning Conflicts of Interest Threatening to Prevent NHI From Reaching its Full Value Potential Highlights the Urgent Need for NHI to Have Truly Independent Directors With the Right Expertise in the Boardroom Given Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details Concerns That NHC Lease Negotiations Will Not Reflect Market Value Given Board Member Conflicts; Lease Likely Has 75% Upside Based on Strong Coverage and Precedent Transactions and Could Boost Earnings 13% Or More Believes NHI Shares Have 50% Upside Over the Next

    2/19/25 8:00:00 AM ET
    $DOC
    $GHL
    $HCP
    Real Estate Investment Trusts
    Real Estate
    Investment Bankers/Brokers/Service
    Finance

    Greenhill & Co. Reports Second Quarter 2023 Results

    Announced definitive agreement for Greenhill to be acquired by Mizuho Financial Group, Inc. in an all-cash transaction at $15 per share Quarterly revenues of $71.4 million, up 98% from prior year's second quarter Year to date revenues of $121.1 million, up 49% from the same period in 2022 Compensation ratio of 54% for the quarter; 82% for the year to date period Operating margin of 21% for the quarter Recruited two additional Managing Directors during the quarter Greenhill & Co., Inc. (NYSE:GHL) today reported revenues of $71.4 million, net income of $4.4 million and diluted earnings per share of $0.21 for the quarter ended June 30, 2023. The Firm's second quarter

    8/9/23 4:05:00 PM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    Lifshitz Law PLLC Announces Investigations of CWBR, GHL, PDCE, and VECT

    NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of CWBR and Morphogenesis, Inc. Under the terms of the proposed merger, CWBR shareholders will receive a dividend equal to approximately 3.30 shares of CWBR common stock. Following the merger, pre-merger CohBar shareholders are expected to own approximately 15% of the outstanding equity of the combined company. If you are a CWBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-

    6/3/23 8:17:00 PM ET
    $CWBR
    $GHL
    $PDCE
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    $GHL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Greenhill downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded Greenhill from Mkt Perform to Underperform and set a new price target of $12.00 from $16.50 previously

    4/28/22 6:12:12 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    Piper Sandler reiterated coverage on Greenhill & Co with a new price target

    Piper Sandler reiterated coverage of Greenhill & Co with a rating of Neutral and set a new price target of $17.00 from $18.50 previously

    3/9/22 6:45:52 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    Greenhill & Co upgraded by Keefe, Bruyette & Woods with a new price target

    Keefe, Bruyette & Woods upgraded Greenhill & Co from Underperform to Market Perform and set a new price target of $15.50

    7/14/21 5:05:57 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    $GHL
    SEC Filings

    View All

    SEC Form 15-12G filed by Greenhill & Co. Inc.

    15-12G - GREENHILL & CO INC (0001282977) (Filer)

    12/11/23 4:03:05 PM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    SEC Form S-8 POS filed by Greenhill & Co. Inc.

    S-8 POS - GREENHILL & CO INC (0001282977) (Filer)

    12/1/23 8:44:25 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    SEC Form S-8 POS filed by Greenhill & Co. Inc.

    S-8 POS - GREENHILL & CO INC (0001282977) (Filer)

    12/1/23 8:41:52 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    $GHL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Ferro Kevin returned 81,495 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - GREENHILL & CO INC (0001282977) (Issuer)

    12/1/23 9:08:03 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    Wyles David returned 98,707 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - GREENHILL & CO INC (0001282977) (Issuer)

    12/1/23 9:05:56 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    Ekman Ulrika returned 10,205 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - GREENHILL & CO INC (0001282977) (Issuer)

    12/1/23 9:03:36 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    $GHL
    Financials

    Live finance-specific insights

    View All

    Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors

    Believes That Incremental Changes Since Last Annual Meeting Are Insufficient to Address the Poor Corporate Governance and Concerning Conflicts of Interest Threatening to Prevent NHI From Reaching its Full Value Potential Highlights the Urgent Need for NHI to Have Truly Independent Directors With the Right Expertise in the Boardroom Given Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details Concerns That NHC Lease Negotiations Will Not Reflect Market Value Given Board Member Conflicts; Lease Likely Has 75% Upside Based on Strong Coverage and Precedent Transactions and Could Boost Earnings 13% Or More Believes NHI Shares Have 50% Upside Over the Next

    2/19/25 8:00:00 AM ET
    $DOC
    $GHL
    $HCP
    Real Estate Investment Trusts
    Real Estate
    Investment Bankers/Brokers/Service
    Finance

    Greenhill & Co. Reports Second Quarter 2023 Results

    Announced definitive agreement for Greenhill to be acquired by Mizuho Financial Group, Inc. in an all-cash transaction at $15 per share Quarterly revenues of $71.4 million, up 98% from prior year's second quarter Year to date revenues of $121.1 million, up 49% from the same period in 2022 Compensation ratio of 54% for the quarter; 82% for the year to date period Operating margin of 21% for the quarter Recruited two additional Managing Directors during the quarter Greenhill & Co., Inc. (NYSE:GHL) today reported revenues of $71.4 million, net income of $4.4 million and diluted earnings per share of $0.21 for the quarter ended June 30, 2023. The Firm's second quarter

    8/9/23 4:05:00 PM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    Lifshitz Law PLLC Announces Investigations of CWBR, GHL, PDCE, and VECT

    NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of CWBR and Morphogenesis, Inc. Under the terms of the proposed merger, CWBR shareholders will receive a dividend equal to approximately 3.30 shares of CWBR common stock. Following the merger, pre-merger CohBar shareholders are expected to own approximately 15% of the outstanding equity of the combined company. If you are a CWBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-

    6/3/23 8:17:00 PM ET
    $CWBR
    $GHL
    $PDCE
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    $GHL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Greenhill & Co. Inc. (Amendment)

    SC 13G/A - GREENHILL & CO INC (0001282977) (Subject)

    7/17/23 4:18:36 PM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13D/A filed by Greenhill & Co. Inc. (Amendment)

    SC 13D/A - GREENHILL & CO INC (0001282977) (Subject)

    5/22/23 5:28:29 PM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by Greenhill & Co. Inc. (Amendment)

    SC 13G/A - GREENHILL & CO INC (0001282977) (Subject)

    1/9/23 11:41:53 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance